What are the Future Directions for Interleukins in Cancer Research?
Future directions include the development of interleukin-based combination therapies and the engineering of interleukin molecules to reduce toxicity and enhance efficacy. Researchers are also exploring the use of interleukins in conjunction with other immunotherapies, such as checkpoint inhibitors, to create more effective cancer treatments. Additionally, personalized medicine approaches are being investigated to tailor interleukin therapies to individual patient's tumor profiles and immune response characteristics.
